CmsArticles / Read Only     


News Item

Laboratories want to bundle innovative strength and jointly contribute to more SARS-Cov-2 test capacity in the Netherlands.

The Dutch laboratories have agreed with the Ministry of Health, Welfare and Sport (VWS) to continue to work together to make optimal use of the innovative power, capacity and availability of test materials for SARS-Cov-2 diagnostics in the Netherlands. All parties are convinced that the innovative and diverse Dutch laboratory landscape can contribute to the solution of the Corona pandemic in both the short and long term.

Recently, the Ministry of Health, Welfare and Sport invited the Dutch laboratories for consultation. Present were representatives of the trade association for accredited laboratories in the Netherlands (Fenelab), the Association of Medical Microbiological Laboratories (VMML), the Cooperating Physician Laboratories in the Netherlands (SAN), the Association of Consultative Chemical Laboratories (VRS) and the pandemic laboratories Sanquin, Royal GD and Wageningen Bioveterinary Research (WBVR). Subjects discussed were the availability of laboratory capacity, the availability of diagnostic materials and the need to guarantee sufficient laboratory capacity in the Netherlands in the short and long term. The limitations in the regulations, the importance of a distinction in specialized medical laboratories and laboratories for mass diagnostics and the need for a good laboratory infrastructure in our country in both the short and long term were discussed. The participating organizations see solutions for the existing bottlenecks.

The Dutch laboratories jointly have a great deal of expertise, which they are happy to offer to the National Coordination Team Diagnostic Chain (LCDK). This includes further expansion of the test capacity, but also innovation in diagnostics and the possible production of test materials in the Netherlands.

The Netherlands has a very diverse and innovative laboratory landscape within which much more capacity for virus diagnostics is available than is currently used. The laboratories already contribute their knowledge every day and deploy their capacity to diagnose the SARS-Cov-2 virus. Expansion of capacity is necessary. A recent inventory makes it clear that the Netherlands has a great deal of laboratory capacity and that our country is strong in innovation in the field of laboratory diagnostics, the laboratories involved like to show. The Dutch laboratories that deploy capacity and expertise in the current approach to the Corona pandemic would like to think together about a permanently improved infrastructure for laboratory research in the Netherlands.

For information about this press release and about Fenelab, please contact the secretary, Mr. drs. Edwin Zoontjes (0630062189, See further

download PDF